ECM-degrading enzymes and compounds such as elastase, collagenase I, angiotensin II (AngII), and lysyl oxidase (LOX) inhibitors like β-aminopropionitrile (BAPN) play a key role in the development of modern murine and porcine AAA models8,9. This evidence concerns the gene LOX and triple-A syndrome.